DRG Instruments GmbH
More than 50 Years of Innovative Diagnostics!
DRG International, Inc., founded in 1970, is a a leading manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries through a network of DRG subsidiaries and local distributors.
The German division, DRG Instruments GmbH, founded in 1973, is located in Marburg and specializes in the development and production of innovative ELISAs and Chemiluminescent assays, both for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function and many more.
DRG is also the manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for Immunoassays and Clinical Chemistry.
DRG operates in accordance with the FDA 21 CFR 820 Quality System Regulation as well as the ISO 13485:2016 and MDSAP (Medical Device Single Audit Program) by TÜV Rheinland.
Recently BioCheck Inc announced the acquisition of DRG International Inc. Leveraging BioCheck’s assay development capabilities with DRG’s development center, the combined companies are well positioned to rapidly scale availability of current tests and develop novel IVD tests for several diseases in the future globally to over 110 countries.